BRIEF published on 05/23/2024 at 16:20, 1 year 6 months ago Forma.ai Acquires SeaMonster to Create World's First Activity-Based Sales Incentives Solution Acquisition Forma.ai SeaMonster Sales Incentives Sales Performance Management
BRIEF published on 05/23/2024 at 16:20, 1 year 6 months ago Forma.ai acquiert SeaMonster pour créer la première solution d'incitation à la vente basée sur l'activité au monde Acquisition Forma.ai Monstre Des Mers Incitatifs À La Vente Gestion Des Performances Commerciales
PRESS RELEASE published on 05/23/2024 at 16:15, 1 year 6 months ago Forma.ai Acquires SeaMonster to Create World's First Activity-Based Sales Incentives Solution Forma.ai acquires SeaMonster, enhancing sales activity monitoring and incentivization capabilities, boosting motivation and revenue growth for sales teams Revenue Growth Forma.ai SeaMonster Sales Activity Monitoring Incentivization
Published on 12/18/2025 at 00:00, 3 hours 55 minutes ago Right Season Investments Announces Name Change to FutureGen Industries Corp.
Published on 12/17/2025 at 23:15, 4 hours 40 minutes ago Northern Superior Announces the Ratio for the Distribution of the Common Shares in the Capital of ONGold Resources Ltd.
Published on 12/17/2025 at 15:00, 12 hours 55 minutes ago BlackBerry Unveils Ground-Up Modernization of BlackBerry AtHoc Mobile Experience to Enable More Intelligent Operations
Published on 12/17/2025 at 14:00, 13 hours 55 minutes ago UniDoc Completes H3 Health Cube Installation in Italy
Published on 12/18/2025 at 01:10, 2 hours 45 minutes ago Samsung To Unveil New AI-Connected Living Lineup at CES 2026
Published on 12/18/2025 at 00:50, 3 hours 5 minutes ago Historic production of graphene enhanced cement successfully completed
Published on 12/17/2025 at 22:05, 5 hours 50 minutes ago Abivax annonce l’acceptation de 22 abstracts sur obefazimod dans les MICI à l’ECCO 2026, dont une présentation orale sur des résultats précliniques antifibrotiques
Published on 12/17/2025 at 22:05, 5 hours 50 minutes ago Abivax Announces Acceptance of 22 Abstracts Evaluating Obefazimod in Inflammatory Bowel Disease at ECCO 2026, Featuring an Oral Presentation on Preclinical Anti-Fibrotic Findings
Published on 12/17/2025 at 21:22, 6 hours 33 minutes ago EQS-Adhoc: DATAGROUP SE: DATAGROUP SE Management Board plans dividend of EUR 0.04 per share
Published on 12/17/2025 at 20:39, 7 hours 16 minutes ago Aeroports de Paris SA | 2026 Airport charges in Paris
Published on 12/17/2025 at 20:39, 7 hours 16 minutes ago Aeroports de Paris SA | Tarifs des redevances aeroportuaires 2026 à Paris
Published on 12/17/2025 at 19:30, 8 hours 25 minutes ago Evolution de la composition du Conseil d’Administration
Published on 12/17/2025 at 18:00, 9 hours 55 minutes ago Outstanding Shares and Voting Rights Statement at 30 November 2025
